Sung-Min Bae

Title: The Innovations of Inventor Sung-Min Bae in Seoul, KR

Introduction

Sung-Min Bae is a prolific inventor based in Seoul, South Korea, recognized for his significant contributions to the field of biotechnology. With a total of three patents to his name, Bae's work focuses on enhancing the efficacy and stability of therapeutic proteins, underscoring his role as a key player in biopharmaceutical advancements.

Latest Patents

Among Sung-Min Bae’s latest innovations, two noteworthy patents stand out. The first, titled "Physiologically active polypeptide conjugate having prolonged in vivo half-life," describes a protein conjugate designed to enhance in vivo stability and extend the half-life of physiological activity in the bloodstream. This invention incorporates a physiologically active polypeptide, a non-peptidic polymer, and an immunoglobulin, contributing to the development of safer polypeptide drugs while minimizing immune responses.

The second patent, "Modified human granulocyte-colony stimulating factor and process for producing same," details a process for creating a modified version of human granulocyte-colony stimulating factor (hG-CSF). This innovative approach involves culturing a microorganism that has been engineered with a specific gene sequence. The resultant modified hG-CSF displays alterations in its amino acid structure, significantly enhancing its therapeutic properties.

Career Highlights

Sung-Min Bae has made substantial strides in his career, holding positions in notable companies such as Hanmi Pharm Co., Ltd. and Hanmi Holdings Co., Ltd. His work in these esteemed organizations has facilitated the advancement of pharmaceutical research and the commercialization of biotechnological innovations.

Collaborations

Throughout his professional journey, Bae has collaborated with fellow researchers, including Se-Chang Kwon and Gwan-Sun Lee. These partnerships have fostered a dynamic exchange of ideas and expertise, which has been crucial to the development of his patented technologies.

Conclusion

Sung-Min Bae exemplifies the spirit of innovation within the biopharmaceutical industry. His contributions through patented inventions not only reflect his dedication to research and development but also hold promise for improving therapeutic interventions. As he continues to work on groundbreaking projects, the impact of his inventions is set to advance healthcare and enhance patient outcomes.